• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    NYSE Content Update: Eli Lilly to Celebrate 150 Years of Scientific Innovation

    5/11/26 8:55:00 AM ET
    $DAR
    $ICE
    $LLY
    $OFRM
    Packaged Foods
    Consumer Staples
    Investment Bankers/Brokers/Service
    Finance
    Get the next $DAR alert in real time by email

    NYSE issues a pre-market daily advisory direct from the trading floor.

    NEW YORK, May 11, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. 

    Ashley Mastronardi delivers the pre-market update on May 11th

    • Equities are lower Monday morning after President Trump called an Iranian counteroffer to end the conflict in the Middle East 'totally unacceptable.'
    • Intercontinental Exchange's (NYSE:ICE) Head of Mortgage and Housing Market Research Andy Walden will break down the May Mortgage Monitor on NYSE Live.
    • Eli Lilly (NYSE:LLY) CFO Lucas Montarce will join NYSE Live to discuss the company's latest milestone and takeaways from its recent earnings.
    • Once Upon a Farm's (NYSE:OFRM) behind-the-scenes footage of its February IPO will air on NYSE Live, providing viewers with new looks from the historic moment.  

    Opening Bell

    Eli Lilly (NYSE:LLY) celebrates its 150th anniversary of founding

    Closing Bell

    Darling Ingredients (NYSE:DAR) celebrates its Investor Day and path to long-term growth

    For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com

    Silver Bow Mining at the NYSE on May 8th

    NYSE Logo (PRNewsfoto/New York Stock Exchange)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nyse-content-update-eli-lilly-to-celebrate-150-years-of-scientific-innovation-302768195.html

    SOURCE New York Stock Exchange

    Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/May2026/11/c7380.html

    Get the next $DAR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DAR
    $ICE
    $LLY
    $OFRM

    CompanyDatePrice TargetRatingAnalyst
    Darling Ingredients Inc.
    $DAR
    4/28/2026$58.00 → $72.00Buy
    TD Cowen
    Once Upon a Farm PBC
    $OFRM
    4/20/2026$26.00 → $18.00Hold
    TD Cowen
    Intercontinental Exchange Inc.
    $ICE
    4/8/2026$190.00Outperform
    Keefe Bruyette
    Eli Lilly and Company
    $LLY
    3/17/2026$850.00Hold → Reduce
    HSBC Securities
    Intercontinental Exchange Inc.
    $ICE
    3/6/2026$188.00Hold → Buy
    Deutsche Bank
    Once Upon a Farm PBC
    $OFRM
    3/3/2026$26.00In-line
    Evercore ISI
    Once Upon a Farm PBC
    $OFRM
    3/3/2026$43.00Buy
    Goldman
    Once Upon a Farm PBC
    $OFRM
    3/3/2026Outperform
    William Blair
    More analyst ratings

    $DAR
    $ICE
    $LLY
    $OFRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    General Counsel Surdykowski Andrew J exercised 2,065 shares at a strike of $57.31 and sold $693,073 worth of shares (4,573 units at $151.56) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 45,473 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    5/28/26 4:30:06 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Director Bowen Sharon sold $100,904 worth of shares (667 units at $151.28) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 15,077 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    5/27/26 4:30:07 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    Director Farooqui Duriya M was granted 1,538 shares, increasing direct ownership by 11% to 15,837 units (SEC Form 4)

    4 - Intercontinental Exchange, Inc. (0001571949) (Issuer)

    5/20/26 4:30:28 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $DAR
    $ICE
    $LLY
    $OFRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause

    In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant weight across all stages of menopause, despite the additional challenge of living with type 2 diabetesAcross studies, women taking Foundayo saw meaningful reductions in their waist circumference, a measure associated with reduced abdominal fat and cardiometabolic riskINDIANAPOLIS, June 7, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY), the maker of Zepbound (tirzepatide), today announced results demonstrating that women with obesity or overweight who took the highest dose of Foundayo experienced signi

    6/7/26 11:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complications

    In TRIUMPH-1, participants on retatrutide 12 mg lost an average of 70.3 lbs (28.3%) over 80 weeks, with 65.3% achieving a BMI below 30, no longer meeting the BMI criteria for obesityIn addition to weight loss, retatrutide reduced knee osteoarthritis pain by up to 4.3 points (73.1%) and moderate-to-severe obstructive sleep apnea severity by up to 36.1 events per hour (60.6%)In TRANSCEND-T2D-1, participants on retatrutide achieved A1C reductions of up to 2.0% and weight loss of up to 36.6 lbs (16.8%) at 40 weeks, with up to 46% achieving a normal A1CINDIANAPOLIS, June 6, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), tod

    6/6/26 2:30:00 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FutureCorp Launches to Bring Frontier Economies to Public Markets

    New firm to operate publicly listed vehicles to give investors access to the industrial space economy Launched by alumni from SpaceX, Palantir, NYSE, Surf Air, Anuvu First vehicle begins trading today: FutureCorp Space Acquisition 1 (NYSE:FTRA) priced an IPO with $200 million in gross proceeds FutureCorp LLC (together with its affiliates, "FutureCorp"), a new investment firm that seeks to connect frontier economies with public-market investors, has announced its launch. FutureCorp expects to sponsor publicly listed vehicles focused on next decade's frontier economies. This will include a series of special purpose acquisition companies and publicly traded funds holding late-stage pr

    6/5/26 11:34:00 AM ET
    $ICE
    $PLTR
    $SRFM
    Investment Bankers/Brokers/Service
    Finance
    Computer Software: Prepackaged Software
    Technology

    $DAR
    $ICE
    $LLY
    $OFRM
    Leadership Updates

    Live Leadership Updates

    View All

    NYSE Content Update: AI Data Platform DDN Appoints Guido Torrini as Finance Chief

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 24, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 24thEquities are little changed this morning after President Trump's 10% global levies officially went into effect early today.H&R Block CEO Curtis Campbell will join NYSE Live today to share why this tax season is particularly 'complex.'Amer Sports says it delivered 27% revenue growth in 2025 during its Q4 earnings

    2/24/26 8:55:00 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    NYSE Content Update: USA TODAY Co. Rings Opening Bell to Celebrate Rebrand

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 17, 2026 /CNW/ --  The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 17thStocks are down Tuesday morning ahead of a shortened trading week after markets were closed yesterday for Presidents Day.Leaders from Payments platform, Bolt, and Digital Identity Company, Socure, are set to join NYSE Live to talk about their latest collaboration that they believe will Supercharge E-commerce id

    2/17/26 8:55:00 AM ET
    $ICE
    $TDAY
    Investment Bankers/Brokers/Service
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    Lilly to acquire Orna Therapeutics to advance cell therapies

    Orna's in vivo CAR-T pipeline includes potential best-in-class programs to reset the immune system and address B cell-driven autoimmune diseases Acquisition provides a broad platform for long-term innovation in genetic medicine and in vivo cell engineering INDIANAPOLIS and WATERTOWN, Mass., Feb. 9, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient's own body to generate cell

    2/9/26 7:00:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DAR
    $ICE
    $LLY
    $OFRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Robb Walter E Iv was granted 140,415 shares and bought $99,990 worth of shares (5,555 units at $18.00) (SEC Form 4)

    4 - Once Upon a Farm, PBC (0001696556) (Issuer)

    2/9/26 8:30:42 PM ET
    $OFRM
    Packaged Foods
    Consumer Staples

    EVP & CFO Montarce Lucas bought $494,627 worth of shares (715 units at $691.79), increasing direct ownership by 5% to 14,685 units (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    8/15/25 4:13:02 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Alvarez Ralph bought $500,473 worth of shares (758 units at $660.25) (SEC Form 4)

    4 - ELI LILLY & Co (0000059478) (Issuer)

    8/14/25 4:12:51 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DAR
    $ICE
    $LLY
    $OFRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Eli Lilly and Company

    SC 13G/A - ELI LILLY & Co (0000059478) (Subject)

    10/23/24 5:17:34 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Eli Lilly and Company (Amendment)

    SC 13G/A - ELI LILLY & Co (0000059478) (Subject)

    2/13/24 5:04:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Darling Ingredients Inc. (Amendment)

    SC 13G/A - DARLING INGREDIENTS INC. (0000916540) (Subject)

    2/13/24 5:02:32 PM ET
    $DAR
    Packaged Foods
    Consumer Staples

    $DAR
    $ICE
    $LLY
    $OFRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Darling Ingredients with a new price target

    TD Cowen reiterated coverage of Darling Ingredients with a rating of Buy and set a new price target of $72.00 from $58.00 previously

    4/28/26 6:53:40 AM ET
    $DAR
    Packaged Foods
    Consumer Staples

    TD Cowen reiterated coverage on Once Upon a Farm with a new price target

    TD Cowen reiterated coverage of Once Upon a Farm with a rating of Hold and set a new price target of $18.00 from $26.00 previously

    4/20/26 9:22:10 AM ET
    $OFRM
    Packaged Foods
    Consumer Staples

    Keefe Bruyette resumed coverage on Intercontinental Exchange with a new price target

    Keefe Bruyette resumed coverage of Intercontinental Exchange with a rating of Outperform and set a new price target of $190.00

    4/8/26 8:36:42 AM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    $DAR
    $ICE
    $LLY
    $OFRM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 7, 2024 - FDA Roundup: May 7, 2024

    For Immediate Release: May 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for midomafetamine (MDMA) capsules, submitted by Lykos Therapeutics, for the treatment of post-traumatic stress disorder. The committ

    5/7/24 4:10:24 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 5, 2023 - FDA Roundup: December 5, 2023

    For Immediate Release: December 05, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, registration opened for the FDA’s virtual Rare Disease Day on Friday, March 1, 2024. This year’s Rare Disease Day is dedicated to patients and health care professionals. Panels will discuss efforts to address the unique challenges with developing treat

    12/5/23 5:00:21 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DAR
    $ICE
    $LLY
    $OFRM
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Once Upon a Farm PBC

    SCHEDULE 13G - Once Upon a Farm, PBC (0001696556) (Subject)

    5/27/26 4:11:34 PM ET
    $OFRM
    Packaged Foods
    Consumer Staples

    SEC Form 144 filed by Intercontinental Exchange Inc.

    144 - Intercontinental Exchange, Inc. (0001571949) (Subject)

    5/20/26 4:35:28 PM ET
    $ICE
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 8-K filed by Eli Lilly and Company

    8-K - ELI LILLY & Co (0000059478) (Filer)

    5/20/26 4:30:32 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $DAR
    $ICE
    $LLY
    $OFRM
    Financials

    Live finance-specific insights

    View All

    Once Upon a Farm Reports First Quarter 2026 Financial Results

    First quarter net sales increased 44% year-over-year to $73 million Raising 2026 net sales outlook to $313 million to $323 million Once Upon a Farm, PBC (NYSE:OFRM) (or the "Company"), a leading high-growth company driving systemic improvement in childhood nutrition, today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Compared to Prior Year Period Net sales increased 43.7% to $72.7 million Gross margin of 40.8% compared to 37.7% Net loss of $15.8 million compared to a net loss of $19.5 million Adjusted EBITDA1 loss of $3.1 million compared to a loss of $7.5 million "Our first quarter results were excellen

    5/7/26 4:05:00 PM ET
    $OFRM
    Packaged Foods
    Consumer Staples

    Lilly declares second-quarter 2026 dividend

    INDIANAPOLIS, May 4, 2026 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE:LLY) has declared a dividend for the second quarter of 2026 of $1.73 per share on outstanding common stock.The dividend is payable on June 10, 2026, to shareholders of record at the close of business on May 15, 2026.About LillyLilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to

    5/4/26 11:11:00 AM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NYSE Content Update: Stocktwits Cashtag Awards Takes Place at NYSE Today

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, May 4, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on May 4thStocks are down Monday morning after President Trump announced over the weekend that 'Project Freedom' would get underway in the Strait of Hormuz today.The Stocktwits Cashtag Awards will be in the spotlight at the NYSE this evening, honoring innovators in finance.The ETF CRTR Economy, which aims to drive awareness of th

    5/4/26 8:55:00 AM ET
    $ICE
    $MA
    $SO
    Investment Bankers/Brokers/Service
    Finance
    Real Estate
    Electric Utilities: Central